At the Guardian, Jenny Rohn describes one ongoing approach to promote equality in the sciences.
The new firm, created by Syncona and Cancer Research Technology, has raised $17.5 million to support development of individualized therapies targeted to tumor neoantigens.
Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.
A suite of papers from the Blueprint project suggests that epigenetic profiling may be ready for clinical use.
A genome-wide association study involving nearly 6,000 individuals identified variants linked to nose-related features and chin protrusion in Latin Americans.
The UK-based startup has developed a prototype intended to attract both experienced molecular and genetics researchers and enthusiastic amateurs.
Through a genome-wide association study, University College London researchers have linked certain SNPs to hair shape, graying, and unibrow, among other traits.
The goal is to detect both clonal and subclonal variations and to demonstrate how Natera's technology can help improve cancer patient care and treatment outcomes.
Faster sequencing of Mycobacterium tuberculosis from sputum samples and analysis of resistance genes could enable better disease treatment, the researchers said.
A study comparing DNA extracted from standardized blocks of FFPE showed variability among experienced molecular pathology labs.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.
National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.